Nederlands

Rapid and convenient preparation of small-sized metal nanoparticles using microchip lasers

920
2024-01-30 13:53:33
Bekijk vertaling

Liquid pulse laser ablation is a reliable and versatile technique for producing metal nanoparticles in solution. Its advantages include no reducing agent, simple operation, high purity, no need for purification steps, and environmental processing conditions, making it the preferred method for traditional metal NP preparation.

The widespread adoption of PLAL in scientific and industrial research has demonstrated its practicality. However, the size and maintenance cost of traditional laser sources pose significant challenges for laboratories, especially those that are not specialized in laser science.

Recognizing these obstacles, Professor Yinghong Sakurai and Professor Yumi Yayama from Osaka University, along with their team, turned their attention to microchip laser systems. MCL, developed by the Taira team at the Institute of Molecular Science, is a compact, low-power giant pulse laser system with a cavity length of less than 10 mm, making it ideal for standard organic synthesis laboratories.

Although MCL has size advantages, the applicability of its specifications to gold target PLAL is still unclear. The research team aims to understand how differences in instrument specifications affect the results of gold PLAL, with the aim of further promoting desktop synthesis and direct application of NPs for catalytic purposes.

In a study published in the Journal of Industrial Chemistry and Materials, the team used MCL to study the PLAL of gold, focusing on the effects of small laser pulse energy, short pulse duration, and low repetition frequency on ablation efficiency. The results indicate that although the pulse energy of MCL is much smaller compared to traditional high-power lasers, it exhibits relatively higher ablation efficiency.

"Our research provides new insights into the preparation of Au NPs using compact MCL systems. Importantly, it opens up avenues for developing new catalytic reactions in standard synthetic chemistry laboratories for highly reactive NPs directly prepared using MCL," said Sakurai.

The research team includes Barana Sandakelum Hettiaracchi, Yusuke Takaoka, Yuta Uetake, Yumi Yakiyama and Mihoko Maruyama, Yusuke Mori, Hiroshi Y. Yoshikawa and Hidehiro Sakurai from Osaka University; And Hwan Hong Lim and Takunori Taira from the Institute of Molecular Science.

Source: Laser Net

Gerelateerde aanbevelingen
  • The 2025 Munich Laser Exhibition has come to a successful conclusion

    Around 1,400 exhibitors and 44,000 visitors created “optimistic atmosphere”, says Messe München.Laser World of Photonics 2025 in Munich, Germany, came to a close on Friday, having set a new record for number of exhibitors and new innovations, said the organizer Messe München. Last week, 1,398 exhibitors from 41 countries presented the full spectrum of photonic technologies to around 44,000 visitor...

    06-30
    Bekijk vertaling
  • Coherent Axon laser won the 2023 Business Innovation Award from the British Physical Society

    One of the laser leaders in the field of life sciences, Coherent Gao Yi (New York Stock Exchange: COHR), recently announced that its Axon laser won the 2023 Business Innovation Award at the awards ceremony held by the British Physical Society on October 30th.Dr. Vincent D. Mattera, Jr., Chairman and CEO of Coherent, stated that, Coherent, especially our team at the Center for Excellence in Ultrafa...

    2023-11-03
    Bekijk vertaling
  • Research Progress: Extreme Ultraviolet Photolithography

    Recently, the semiconductor industry has adopted Extreme Ultraviolet Lithography (EUVL) technology. This cutting-edge photolithography technology is used for the continuous miniaturization of semiconductor devices to comply with Moore's Law. Extreme ultraviolet lithography (EUVL) has become a key technology that utilizes shorter wavelengths to achieve nanoscale feature sizes with higher accuracy a...

    2024-12-09
    Bekijk vertaling
  • Marvel Fusion received an additional € 50 million in Series B funding

    Recently, Marvel Fusion, which focuses on developing laser fusion energy systems, announced that the company has received an additional € 50 million in Series B funding. This latest investment is provided by EQT Venture Capital and Siemens Energy, and is also the first investment of the European Innovation Council (EIC) fund in fusion energy. In addition to the 63 million euros investment announce...

    04-08
    Bekijk vertaling
  • 330 million US dollars! This laser ophthalmic treatment developer has been acquired

    Recently, according to a report submitted by BioLight to the Tel Aviv Stock Exchange, Swiss American pharmaceutical and medical device giant Alcon Pharmaceuticals is acquiring Israeli medical technology company Belkin Vision.It is reported that BioLight will sell its 4% stake in Belkin Vision, which may be worth up to $330 million based on the milestones established in the transaction.Belkin Visio...

    2024-05-06
    Bekijk vertaling